Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06008431 · ClinicalTrials.gov registry record · NA
Non-invasive Brain Stimulation to Improve Unsteady Gait in Older Adults (StimGait)
A NA study of Mobility Limitation and Fall, sponsored by Hebrew SeniorLife.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT06008431: Completed NA study of Mobility Limitation and Fall, sponsored by Hebrew SeniorLife.
NCT06008431 is a NA study of Mobility Limitation and Fall that has completed, run by Hebrew SeniorLife. The registered enrollment target is 27 participants, below the 255-participant average among 28 other Mobility Limitation trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06008431, a NA study of Mobility Limitation and Fall, has completed, sponsored by Hebrew SeniorLife.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
Walking is a complex and continuous task that entails repetitive motions of the body. Relatively high gait variability sensitively predicts falls and cognitive decline in older adults. Previous work has identified an unique brain network relationship linked to gait variability and its relevant cognitive function (i.e., sustained attention). This project aims to develop a non-invasive brain stimulation montage designed to modulate the shared brain networks dynamics and to demonstrate its effects on resting state functional connectivity, gait and cognitive performance in older adults at risk for falls.
Primary Outcome
This measure is captured by both Mobility Lab (APDM Inc) and the smart phone App. Gait variability is defined as the coefficient of variation to validated stride times.
Conditions Studied
Interventions
- DEVICE Transcranial direct current stimulation (tDCS) (active)
- DEVICE Transcranial direct current stimulation (tDCS) (Sham)
Study Locations (1)
Massachusetts
- Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2025-11-20 |
| Phase | NA |
What the finished NCT06008431 record still lists
NCT06008431 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 255-participant average among 28 other Mobility Limitation trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Mobility Limitation appearing as the primary indexed condition, and to 2 interventions - of which Transcranial direct current stimulation (tDCS) (active) is the first listed.
NCT06008431 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06008431 about?
NCT06008431 is a clinical study titled "Non-invasive Brain Stimulation to Improve Unsteady Gait in Older Adults (StimGait)". Walking is a complex and continuous task that entails repetitive motions of the body. Relatively high gait variability sensitively predicts falls and cognitive decline in older adults. Previous work has identified an unique brain network relationship linked to gait variability and its relevant cogni...
What is the current status of trial NCT06008431?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2024-06-03. Estimated completion is 2025-11-20.
What conditions does trial NCT06008431 study?
This clinical trial studies the following conditions: Mobility Limitation, Fall, Gait, Unsteady.
What interventions are being tested in trial NCT06008431?
The interventions under investigation include: Transcranial direct current stimulation (tDCS) (active) (DEVICE), Transcranial direct current stimulation (tDCS) (Sham) (DEVICE).
Who is sponsoring clinical trial NCT06008431?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06008431 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mobility Limitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06008431's enrollment target sits among peer trials
27 22nd of 28 higher than 7 of 28 other Mobility Limitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mobility Limitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV
ACTIVE NOT RECRUITING · NA
-
Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance
ACTIVE NOT RECRUITING · NA
-
Randomized Clinical Trial to Improve Mobility After Hospitalization
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI